Trichilemmocarcinoma Angiomyofibroblastoma Adenomyoepithelioma Ectomesenchymoma Cystadenocarcinofibroma Lymphangioleiomyomatosis

Tricilemmocarcinoma is in the basal cell series, 8102/3, and is reportable.

Angiomyofibroblastoma is a benign tumor in the fibroma series.

Adenomyoepithelioma is a benign tumor in the complex mixed and stromal neoplasms

Ectomesenchymoma is a malignancy in the myomatous tumor series.

Cystadenocarcinofibroma is part of three new codes (8313/3 = clear cell cystadenocarcinofibroma ; 9014/3 = serous cystadenocarcinofibroma; and 9015 = mucinous cystadenocarcinofibroma) and is reportable.

And the winner (at 11 syllables!) is a borderline condition, lymphangioleiomyomatosis.